<DOC>
	<DOCNO>NCT00645268</DOCNO>
	<brief_summary>To determine effect erectile function population type 2 diabetic men erectile dysfunction undergone follow treatment regimen : pre-treatment daily dose double-blind sildenafil versus placebo 4 week ( Phase I ) follow as-needed , flexible-dose , open-label treatment phase sildenafil 12 week ( Phase II ) . To assess safety tolerability dose regimen investigate effect endothelial function subject 's response Self-Esteem And Relationship ( SEAR ) questionnaire .</brief_summary>
	<brief_title>A Multicenter , Double-Blind Study Evaluate Effect Pretreatment With Daily Dose Sildenafil As-Needed Efficacy Viagra Men With Erectile Dysfunction Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>Patients document clinical diagnosis erectile dysfunction , sexual partner duration study , HbAlc le equal 10 screening . Type 2 diabetic patient currently insulin combination therapy oral hypoglycemic agent exclude . Excluded subject take 6 dos PDE5 inhibitor and/or take last dose less 4 week prior screen visit ; subject rest sit and/or stand hypotension ( BP &lt; 90/50mmHg ) hypertension ( BP &gt; 170/110mmHg ) ; subject significant cardiovascular disease , include cardiac failure , myocardial infarction , unstable angina , stroke transient ischemic attack ( TIA ) , symptomatic clinically significant cardiac arrhythmia include atrial fibrillation last 3 month .</criteria>
	<gender>Male</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>